Cryomass Technologies's quarterly market cap
increased
from Mar. 2023 ($28.67 Mil) to Jun. 2023 ($28.79 Mil) but then
declined
from Jun. 2023 ($28.79 Mil) to Sep. 2023 ($19.47 Mil).
Cryomass Technologies's annual market cap
increased
from Dec. 2020 ($19.30 Mil) to Dec. 2021 ($53.18 Mil) but then
declined
from Dec. 2021 ($53.18 Mil) to Dec. 2022 ($37.51 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Cryomass Technologies's Enterprise Value for Today is $9.48 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Cryomass Technologies's Market Cap
For the Drug Manufacturers - Specialty & Generic subindustry, Cryomass Technologies's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cryomass Technologies's Market Cap Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Cryomass Technologies's Market Cap distribution charts can be found below:
* The bar in red indicates where Cryomass Technologies's Market Cap falls into.
Cryomass Technologies Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Cryomass Technologies's Market Cap for the fiscal year that ended in Dec. 2022 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cryomass Technologies (OTCPK:CRYM) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Cryomass Technologies Market Cap Related Terms
Thank you for viewing the detailed overview of Cryomass Technologies's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Cryomass Technologies (Cryomass Technologies) Business Description
Cryomass Technologies Inc designs, manufactures, and licenses field-mobile equipment for the handling of harvested cannabis, hemp, and other high-value plant material. The company owns patented technology that utilizes liquid nitrogen to fully separate, collect and protect the high-value compounds from the harvested plant. The company's offerings include refinement systems and monitoring and control systems.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CRYM has been successfully added to your 